“Pharmacotherapeutic follow-up in patients with type 1 diabetes in context of judicialization: possibility optimize costs” (2023) Brazilian Journal of Pharmaceutical Sciences, 59, p. e23264. doi:10.1590/s2175-97902023e23264.